- Title
- Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
- Creators
- M. A. Nauck (Author)M. W. Stewart (Author)C. Perkins (Author)A. Jones-Leone (Author)F. Yang (Author)C. Perry (Author)R. R. Reinhardt (Author)Marc S. Rendell (Author) - Creighton University
- Additional links
- http://dx.doi.org/10.1007/s00125-015-3795-1
- Publication Details
- Diabetologia, Vol.59(2), pp.266-274
- Number of pages
- 266-274
- Identifiers
- 991005932290502656
- Academic Unit
- School of Medicine; Internal Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
Diabetologia, Vol.59(2), pp.266-274
02/2016
PMID: 26577795
Metrics
4 Record Views